Skip to content
★ Sign in to follow
PB

Paul B. Cleveland

CEO
Adverum Biotechnologies, Inc.Affymax IncSangamo Therapeutics, Inc
Total declarations
24
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€1.4M

Latest filing published 14 Jun 2017 for Adverum Biotechnologies, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

No signal scores available.

Paul B. Cleveland: trading record in brief

Paul B. Cleveland discloses dealings in 3 companies, chiefly Sangamo Therapeutics, Inc, Affymax Inc and Adverum Biotechnologies, Inc. Between 25 February 2010 and 12 June 2017, the trades on record add up to 24 filings.

Every open-market trade on record is a sale: 12 sales worth €1.4M. Besides market trades, the filings include 2 share grants and 10 option exercises.

The record was last updated on 14 June 2017 with a share grant in Adverum Biotechnologies, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Paul B. Cleveland

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations